Skip to main content

Table 1 Comprehensive Western intervention for stable COPD patients

From: Comparison of conventional medicine, TCM treatment, and combination of both conventional medicine and TCM treatment for patients with chronic obstructive pulmonary disease: study protocol of a randomized comparative effectiveness research trial

Classification

Therapy

Group A

Salbutamol (Ventolin®, GlaxoSmithKline) 100 μg/dose, 200 inhalations. Dosing: one inhalation of 100 μg each time (when needed), and the maximum dose is 8 to 12 inhalations a day

Group B

Formoterol (Oxis Turbuhaler®, AstraZeneca), 4.5 μg/dose, 60 inhalations. Dosing: one inhalation of 4.5 μg each time, twice daily

Group C

Salmeterol/fluticasone (Seretide®, GlaxoSmithKline), 50/500 μg/dose, 60 inhalations. Dosing: one inhalation of 50/500 μg each time, twice daily

Group D

Salmeterol/fluticasone (Seretide®, GlaxoSmithKline), 50/500 μg/dose, 60 inhalations. Dosing: one inhalation of 50/500 μg each time, twice daily

Back to article page

Trials

ISSN: 1745-6215